Relay Therapeutics said on Monday interim data from an early-stage study of its combination drug for breast cancer showed it ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other stocks on Jim Cramer’s radar. Jim Cramer often reflects on how he would reform the American ...

People on social media are claiming the slogan for vice president and Democratic presidential candidate Kamala Harris has ties to Nazism. “Kamala’s ‘Strength Through Joy’ messaging derives ...

Novartis AG (NYSE:NVS) is a Swiss multinational pharmaceutical company that specializes in innovative drugs across key areas like oncology, rare diseases, neuroscience, and cardio-metabolic ...

Governor Kimani Wamatangi has unveiled a new Kiambu county logo, removing the previous Kikuyu slogan to better reflect the county's diverse nature The updated logo features a new slogan, "Delivering ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Novartis’ blood cancer sculpture tour has reached a new destination. The Swiss drugmaker, which put the sculptures on show in London one year ago, is marking this year’s Blood Cancer Awareness ...

*I seem to be having a hard time keeping this to 10 items each week. So maybe I should rename it after something more expansive, but still apropos. The Big Sky, perhaps? 1. Dan Lanning was right ...

The claim: Democrats are using the Nazi slogan 'Strength Through Joy' An Aug. 16 Instagram post (direct link, archive link) from actor Robert Davi includes a link to the Wikipedia entry for ...

Lindy Biosciences has announced an exclusive global licensing agreement and strategic collaboration with Novartis Pharma AG. The deal centres on Lindy’s microglassification technology, which ...

Natco Pharma has submitted to the U.S. Food and Drug Administration an abbreviated new drug application for a generic version of Novartis’ cancer drug Tabrecta (capmatinib hydrochloride).

The trial compared the efficacy of Novartis’ Leqvio as a single agent against ezetimibe and a placebo. Credit: VILTVART/Shutterstock. Novartis has revealed that its Phase III V-MONO clinical trial of ...